Oscar Health, Inc. Hits New 52-Week High of $30.09

Oscar Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 30.09 on June 23, 2026. This achievement marks a notable increase from its 52-week low of USD 10.69, reflecting a robust performance over the past year. The stock has demonstrated a remarkable one-year performance of 45.93%, significantly outperforming the S&P 500, which recorded a gain of 22.24% during the same period. As a small-cap company in the healthcare services industry, Oscar Health, Inc. has a market capitalization of USD 3,320 million. Despite facing challenges, including negative operating profits and a return on equity of -45.30%, the stock's recent price movement indicates a shift in market dynamics. The company's price-to-book ratio stands at 3.40, suggesting that investors are valuing the stock at a premium relative to its book value. While the company has reported losses in recent quarters, the substantial increase in stock price highlights the volatility and potential for recovery within the healthcare sector. Investors and market observers will be keen to monitor how Oscar Health navigates its financial landscape moving forward.